Atripla Adherence and Resistance Relationships [II]

Investigator: Steven Deeks, MD
Sponsor: Bristol-Myers Squibb Company

Location(s): United States


The study is recruiting 50 patients initiating or switching to Atripla and comparing them to 250 individuals previously followed in a prospective study of HIV+ low income individuals recruited from homeless shelters, single room occupancy hotels and free meal food lines as part of the UCSF Reach Study. Adherence will be measured through monthly unannounced pill counts and electronic medication monitors.